Novartis India Ltd share price logo

Novartis India Ltd Share Price (500672)

₹923.31.53%

as on

| Source : BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Novartis India Ltd Stock Performance

as on August 26, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹920
    ₹944.05
    downward going graph

    0.36%

    Downside

    2.25%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹744.95
    ₹1,248
    downward going graph

    19.32%

    Downside

    35.17%

    Upside

    downward going graph
Previous Close₹937.60
Open₹938.00
Volume4,820.00
Upper Circuit₹1,125.10
Lower Circuit₹750.10
Day's Low920
Day's High944.05
52 Week Low744.95
52 Week High1,248
1 Month Return-5.64 %
3 Month Return-10.07 %
1 Year Return-17.61 %
3 Year Return+ 26.57 %
5 Year Return+ 38.15 %

Novartis India Ltd Stock Fundamentals & Key Indicators

Check Novartis India Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹2,315.01 Cr

Return on Equity (ROE)

13.19

PE Ratio (TTM)

0

Return on capital employed (ROCE)

16.64

Beta (LTM)

0.55

P/B Ratio

2.47

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

7.3

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Novartis India Ltd Stock's Interest Amongst Investors

-59%

Period Aug 27, 2025 to Jul 28, 2025. Change in 30 Days vs previous period

Search interest for Novartis India Ltd Stock has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.

Novartis India Ltd Financial Results

Get the annual and quarterly financial summary of Novartis India Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

92 (0%)87 (6%)93 (7%)84 (10%)88 (4%)
Net Income

(in ₹ Cr)

26 (0%)20 (21%)25 (25%)29 (15%)28 (6%)
Net Profit Margin27.89% (0%)23.43% (16%)27.37% (17%)34.93% (28%)31.55% (10%)
Value in ₹ crore
DetailsFY22FY23FY24FY25
Total Assets

(in ₹ Cr)

958 (0%)990 (3%)933 (6%)956 (2%)
Total Liabilities

(in ₹ Cr)

266 (0%)214 (20%)188 (12%)171 (9%)
Value in ₹ crore
DetailsFY21FY22FY23FY24FY25
Operating Cash Flow

(in ₹ Cr)

-69 (0%)39 (156%)45 (16%)113 (153%)75 (34%)

Novartis India Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Novartis India Ltd.

  • Novartis India Ltd Earnings Results

    Novartis India Ltd’s net profit jumped 7.3% since last year same period to ₹27.62Cr in the Q1 2025-2026. On a quarterly growth basis, Novartis India Ltd has generated -5.73% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Novartis India Ltd Dividends May,2025

    In the quarter ending March 2025, Novartis India Ltd has declared dividend of ₹25.00 per share on 09 May 2025 - translating a dividend yield of 5.34%.

    Read More about Dividends

Indices Featuring Novartis India Ltd Stock

Check stock indices that include Novartis India Ltd.

BSE Healthcare

₹44,075.94

-1.65 (-739.95%)

BSE Small-Cap

₹52,097.59

-1.68 (-891.75%)

Novartis India Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Novartis India Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
70.68%
0.00
Foreign Institutions
0.19%
0.00
Mutual Funds
0%
0.00
Retail Investors
28.6%
0.00
Others
0.53%
0.02

Novartis India Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Novartis India Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA2,315.017.63%0.00100390
NA325.7431.96%0.63544
NA70.291.79%0.00140
NA64.201.73%0.00-510
NA31.87-5.03%0.001150

Insights on Novartis India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.19% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.68% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 26.8% return, outperforming this stock by 44.4%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 28.60% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.4% return, outperforming this stock by 110.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NOVARTIND stock has moved down by -5.6%

About Novartis India Ltd

Novartis India Limited (NIL) is a subsidiary of the world's second-largest pharmaceutical company, Swiss giant Novartis. Incorporated in 1947, the company has four core segments- Pharmaceuticals, Generics, Over the Counter, and Animal Health. Its history traces back to the middle of the 18th century when Geigy was founded, followed by Ciba in 1860 and then Sandoz in 1886. It was only in 1996 when the three separate entities merged to become Novartis. In 2000, the company acquired products from SmithKline Beecham and started a Joint Effort to Eradicate Tuberculosis (JEET) in India. The Glivec drug was launched in India in 2002 for which they were awarded TERI's Corporate Social Responsibility award. Over the years the company has alligned with various global organisations inlcuding the WHO to help stem the spread of malaria, as well as launching numerous initiatives including the Arogya Parivar in 2008 to target healthcare needs of villagers. Moreover, between 2000 and 2006, it spent over USD 755 million on research for neglected diseases and patient-access programs.

Revenue: ₹87.55Cr as on June 2025 (Q1 FY26)
Net Profit: ₹27.62Cr as on June 2025 (Q1 FY26)
Listing date: 08 Nov, 1994
Chairperson Name: C Snook
OrganisationNovartis India Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOC Snook
E-voting on sharesClick here to vote

Mutual Funds that own Novartis India Ltd Stock

Check out the Mutual Funds with significant holdings in Novartis India Ltd.

FAQs

What is Novartis India Ltd share price today?

Novartis India Ltd share price today stands at ₹923.3, Open: ₹938, Previous Close: ₹937.6, High: ₹944.05, Low: ₹920, 52 Week High: ₹1248, 52 Week Low: ₹744.95 as on .

How to buy Novartis India Ltd shares ?

To buy Novartis India Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 500672 or Novartis India Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Novartis India Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Novartis India Ltd?

Today's traded volume of Novartis India Ltd is 4,820.00. Which means that 4,820.00 shares of Novartis India Ltd were bought and sold on the stock market during today's trading session.

What is Novartis India Ltd's market cap today?

Today's market capitalisation of Novartis India Ltd is ₹2,315.01 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Novartis India Ltd?

Novartis India Ltd’s 52 week high is ₹1248 and 52 week low is ₹744.95. The current share price of Novartis India Ltd is ₹923.3, which is -26.02% down from its 52 week high and 23.94% up from its 52 week low.